Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?
Objective:Although there is no antiviral treatment specific to the virus, favipiravir has entered the treatment routine as an antiviral in our country in May 2020. In this study, in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory distress syndrome (ARDS)...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Galenos Yayinevi,
2021-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|